Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine

Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine

Item
http://www.wikidata.org/entity/Q27487534
Encephalitic alphavirusesmRNA Capping by Venezuelan Equine Encephalitis Virus nsP1: Functional Characterization and Implications for Antiviral ResearchIdentification of thieno[3,2-b]pyrrole derivatives as novel small molecule inhibitors of neurotropic alphavirusesKinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine ProteasePrinciples of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agentsDiscovery of potent broad spectrum antivirals derived from marine actinobacteriaDiscovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo.Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virusNovel inhibitors of neurotropic alphavirus replication that improve host survival in a mouse model of acute viral encephalitis.Natural killer cell mediated pathogenesis determines outcome of central nervous system infection with Venezuelan equine encephalitis virus in C3H/HeN mice.Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand.Synthesis of cyclopentanyl carbocyclic 5-fluorocytosine ((-)-5-fluorocarbodine) using a facially selective hydrogenation approach.A compendium of small molecule direct-acting and host-targeting inhibitors as therapies against alphaviruses.β-D-N(4)-hydroxycytidine is a potent anti-alphavirus compound that induces high level of mutations in viral genome.Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Venezuelan equine encephalitisLipid-Coated Mesoporous Silica Nanoparticles for the Delivery of the ML336 Antiviral to Inhibit Encephalitic Alphavirus Infection
P2860

Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine

Item
http://www.wikidata.org/entity/Q27487534
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine
@ast
Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine
@en
Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine
@nl
type
label
Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine
@ast
Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine
@en
Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine
@nl
prefLabel
Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine
@ast
Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine
@en
Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Treatment of Venezuelan equine encephalitis virus infection with (−)-carbodine
@en
P2093
P2860
P304
P31
P356
10.1016/J.ANTIVIRAL.2008.07.002
P433
P478
P50
P577
P5875
P698
P932